EULAV Asset Management
- SEC CIK
- 0001540826
- Latest filing
- Jul 29, 2026
WST holding history
West Pharmaceutical Services Inc in every 13F filed by EULAV Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WST overviewAll 13F holders of WSTFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −104,616−100.0% | Sold out | Holders |
| Q4 2025 | 104,616 | $28.8M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2025 | 104,616 | $27.4M | 0.6% | −33,000−24.0% | Reduced | Holders |
| Q2 2025 | 137,616 | $30.1M | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 137,616 | $30.8M | 0.8% | −70.0% | Reduced | Holders |
| Q4 2024 | 137,623 | $45.1M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 137,623 | $41.3M | 1.0% | +20.0% | Added | Holders |
| Q2 2024 | 137,621 | $45.3M | 1.2% | +9,000+7.0% | Added | Holders |
| Q1 2024 | 128,621 | $50.9M | 1.4% | +50.0% | Added | Holders |
| Q4 2023 | 128,616 | $45.3M | 1.4% | +14,600+12.8% | Added | Holders |
| Q3 2023 | 114,016 | $42.8M | 1.6% | +45,500+66.4% | Added | Holders |
| Q2 2023 | 68,516 | $26.2M | 1.0% | +57,416+517.3% | Added | Holders |
| Q1 2023 | 11,100 | $3.85M | 0.2% | +11,100 | New | Holders |